Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Langetermijnuitkomsten na stamceltransplantatie bij MS
feb 2017 | Multipele Sclerose